טוען...
Immune Checkpoint Blockade: The Hope for Immunotherapy as a Treatment of Lung Cancer?
Over the past 20 years, immunotherapy has not played a role in the treatment of lung cancer outside of clinical trials. Early trials with vaccines yielded promising results, but phase III trials have yet to show an improvement in survival. Recently, immune checkpoint pathway inhibitors have yielded...
שמור ב:
| הוצא לאור ב: | Semin Oncol |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4732704/ https://ncbi.nlm.nih.gov/pubmed/24565586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2013.12.014 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|